Market Overview

Global Cell Therapy Manufacturing Market, 2018-2030 -


The "Cell
Therapy Manufacturing Market (2nd Edition), 2018-2030"
has been added to's offering.

The "Cell Therapy Manufacturing Market (2nd Edition), 2018-2030" report
provides an extensive study of the rapidly growing market of cell
therapy manufacturing, focusing on contract manufacturers, as well as
cell therapy developers with in-house manufacturing facilities. The
study presents an in-depth analysis of various organizations that are
engaged in this domain across different regions of the globe.

Cell-based therapies have gained significant attention in the overall
biopharmaceutical industry. The personalized nature of these treatment
options render them highly specific and, according to a number of
clinical studies, safe and efficacious. Such therapies are considered to
possess the potential to address various unmet medical needs associated
with the treatment of several types of physiological disorders and
clinical conditions. A number of pharmaceutical companies and investors
have already invested significant capital towards the development and
commercialization of such products.

Around 20 such therapies have been approved; recent approvals include
Baloise (2018), YESCARTA (2017) and Kymriah (2017). It is also worth
highlighting that over 500 cell-based therapy candidates are in
different stages of clinical development, and are being evaluated in
more than 1,000 active clinical studies across various regions of the

The growing number of cell therapy candidates, coupled to their rapid
progression through various phases of clinical development, continues to
create an increasing demand for facilities that offer manufacturing
services for these complex therapies. There is a wide array of industry
players, including well-established companies, mid-sized firms and
start-ups, as well as academic institutes that are significantly
contributing to the production of GMP grade cell therapies. In addition,
several players offer novel technology solutions, aimed at improving and
upgrading existing cell-based therapies and their manufacturing
processes. Most of these players have signed multiple partnerships /
collaborations with an aim to optimize, scale-up and expand the
capabilities for the production of cell-based therapies.

Additionally, stakeholders have received significant support from
governments worldwide, in terms of funding and establishment of
consortiums, to accelerate the transition of these therapies from
laboratories to clinics. Looking at the evolutionary trend so far, we
believe that the cell therapy manufacturing market is poised to steadily
grow, driven by a robust pipeline of therapy candidates and
technological advances aimed at mitigating challenges posed by the
conventional methods of production.

One of the key objectives of the report was to understand the primary
growth drivers and estimate the future size of the market. Based on
parameters, such as increase in number of clinical studies, target
patient population, anticipated adoption of cell-based therapies and
expected variation in manufacturing costs, we have provided an informed
estimate of the likely evolution of the market in the short to mid-term
and mid to long term, for the period 2018-2030. In addition, to account
for the uncertainties associated with the manufacturing of cell-based
therapies and to add robustness to our model, we have provided three
forecast scenarios, portraying the conservative, base and optimistic
tracks of the market's evolution.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Regulatory Landscape

6. Roadmaps: Potential Strategies To Overcome Existing Challenges

7. Automation Technologies For Cell Therapy Manufacturing

8. Cell Therapy Manufacturing: Industry Players

9. Cell Therapy Manufacturing: Non-Industry Players

10. Role Of Non-Profit Organizations

11. Recent Developments

12. Capacity Analysis

13. Cost Price Analysis

14. Market Sizing And Forecast

15. Key Insights

16. SWOT Analysis

17. Conclusion

18. Survey Analysis

19. Interview Transcripts

20. Appendix: Tabulated Data

For more information about this report visit

View Comments and Join the Discussion!